Literature DB >> 18779989

Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn.

Amy L Peterson1, Sara Deatsman, Michele A Frommelt, Kathy Mussatto, Peter C Frommelt.   

Abstract

BACKGROUND: Persistent pulmonary hypertension of the newborn (PPHN) causes morbidity and mortality in neonates. High-frequency ventilation (HFV), inhaled nitric oxide (iNO), and extracorporeal membrane oxygenation (ECMO) are used when conventional treatment fails. This study aimed to identify echocardiographic predictors of progression to these therapies before clinical deterioration.
METHODS: Echocardiographic parameters were compared for survival and need for ECMO, HFV, iNO, and prolonged mechanical ventilation (MV, >or=10 days).
RESULTS: Of 63 neonates, 95% survived, with 14% requiring ECMO, 52% requiring HFV, 67% requiring iNO, and 35% requiring MV. The following echocardiographic indices reflecting left ventricular output were decreased in sicker infants: (1) A decreased ascending aortic velocity time integral indicated an increased likelihood of ECMO (p=0.02), iNO (p=0.01), or MV (p=0.05), (2) Shorter transverse aortic arch antegrade ejection time indicated HFV (p<0.01), iNO (p<0.01), and MV (p=0.03), (3) Absent or retrograde transverse aortic diastolic flow correlated with HFV (p=0.01, iNO (p=0.01), and MV (p<0.01). These sicker patients were more likely to have smaller left ventricular end-diastolic areas (p<0.03 for all) and right-to-left atrial shunting (ECMO, HFV, and MV). There were no differences in survival.
CONCLUSIONS: Decreased left ventricular size and output correlates with the need for advanced therapies in infants with PPHN. Early identification may allow more effective management and placement of neonates at risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779989     DOI: 10.1007/s00246-008-9303-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  14 in total

1.  Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes.

Authors:  M C Walsh-Sukys; J E Tyson; L L Wright; C R Bauer; S B Korones; D K Stevenson; J Verter; B J Stoll; J A Lemons; L A Papile; S Shankaran; E F Donovan; W Oh; R A Ehrenkranz; A A Fanaroff
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

2.  Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study.

Authors:  P P O'Rourke; R K Crone; J P Vacanti; J H Ware; C W Lillehei; R B Parad; M F Epstein
Journal:  Pediatrics       Date:  1989-12       Impact factor: 7.124

3.  Bidirectional flow through the ductus arteriosus in normal newborns: evaluation by Doppler color flow imaging.

Authors:  H Shiraishi; M Yanagisawa
Journal:  Pediatr Cardiol       Date:  1991-10       Impact factor: 1.655

4.  Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

Authors:  J D Roberts; J R Fineman; F C Morin; P W Shaul; S Rimar; M D Schreiber; R A Polin; M S Zwass; M M Zayek; I Gross; M A Heymann; W M Zapol
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

5.  Echocardiographic evidence of improved hemodynamics during inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.

Authors:  C G Ochikubo; F Waffarn; R Turbow; M Kanakriyeh
Journal:  Pediatr Cardiol       Date:  1997 Jul-Aug       Impact factor: 1.655

6.  Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction.

Authors:  Periklis A Davlouros; Philip J Kilner; Tim S Hornung; Wei Li; Jane M Francis; James C C Moon; Gillian C Smith; Tri Tat; Dudley J Pennell; Michael A Gatzoulis
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

7.  Persistent pulmonary hypertension of the newborn. Trends in incidence, diagnosis, and management.

Authors:  J R Hageman; M A Adams; T H Gardner
Journal:  Am J Dis Child       Date:  1984-06

8.  Utility of M-mode echocardiography for early identification of infants with persistent pulmonary hypertension of the newborn.

Authors:  L M Valdes-Cruz; G G Dudell; A Ferrara
Journal:  Pediatrics       Date:  1981-10       Impact factor: 7.124

9.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound.

Authors:  M Berger; A Haimowitz; A Van Tosh; R L Berdoff; E Goldberg
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

10.  Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn.

Authors:  N N Musewe; D Poppe; J F Smallhorn; J Hellman; H Whyte; B Smith; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

View more
  6 in total

1.  A comprehensive study of clinical biomarkers, use of inotropic medications and fluid resuscitation in newborns with persistent pulmonary hypertension.

Authors:  Janardhan Mydam; Marwan Zidan; Nitin Shashikant Chouthai
Journal:  Pediatr Cardiol       Date:  2014-08-09       Impact factor: 1.655

2.  Right ventricular echocardiographic indices predict poor outcomes in infants with persistent pulmonary hypertension of the newborn.

Authors:  Jonathan R Malowitz; Daniel E Forsha; P Brian Smith; C Michael Cotten; Piers C Barker; Gregory H Tatum
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-04-06       Impact factor: 6.875

3.  Accuracy and reliability of qualitative echocardiography assessment of right ventricular size and function in neonates.

Authors:  Aisling Smith; Jyothsna R Purna; Michael P Castaldo; Daniel Ibarra-Rios; Regan E Giesinger; Danielle R Rios; Dany E Weisz; Amish Jain; Afif F El-Khuffash; Patrick J McNamara
Journal:  Echocardiography       Date:  2019-06-27       Impact factor: 1.724

Review 4.  The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1): study protocol and review of literature.

Authors:  Afif El-Khuffash; Patrick J McNamara; Colm Breatnach; Neidin Bussmann; Aisling Smith; Oliver Feeney; Elizabeth Tully; Joanna Griffin; Willem P de Boode; Brian Cleary; Orla Franklin; Eugene Dempsey
Journal:  Matern Health Neonatol Perinatol       Date:  2018-12-03

5.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

Review 6.  Application of Neonatologist Performed Echocardiography in the assessment and management of persistent pulmonary hypertension of the newborn.

Authors:  Willem P de Boode; Yogen Singh; Zoltan Molnar; Ulf Schubert; Marilena Savoia; Arvind Sehgal; Philip T Levy; Patrick J McNamara; Afif El-Khuffash
Journal:  Pediatr Res       Date:  2018-07       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.